课题基金 / 基金详情

Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis

Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis
含屈螺酮的复方口服避孕药与动脉血栓形成的风险
批准号：
254915
负责人：
Filion Kristian B
金额：
$11.26万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=254915&lang=en
关键词：
Cardiovascular Disease Databases Drospirenone Drug Safety Myocardial Infarction Oral Contraceptives Pharmacoepidemiology Side Effects Stroke Thrombosis

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Combined oral contraceptives, or birth control pills, are used to prevent unwanted pregnancies. Worldwide, over 100 million women use birth control pills. One known side effect of taking birth control pills is an increased chance of having blood clots c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
A population-based assessment of pharmacological treatments for gestational diabetes
海外基金